Acupressure shows promise for cancer fatigue
NCT ID NCT03763838
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether acupressure, a technique from Traditional Chinese Medicine, can ease fatigue in ovarian cancer survivors. 171 women who had completed primary cancer treatment were taught to apply pressure to specific points on their bodies daily for six weeks. The study compared real acupressure to a sham version to see if it truly helps.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- acupressure
- What this could lead to
- If it works, this could offer a simple, drug-free way to manage fatigue for ovarian cancer survivors.
- What could go wrong
- This is a completed study, but the results may not apply to all survivors. The sham group also received some pressure, so the true benefit of acupressure is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
171 people
The number who actually took part.
- Started
-
Oct 2019
- Finished
-
Jun 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged 21 and older * Diagnosis of ovarian cancer, stages I to IV * Have average persistent fatigue defined a \>=4 on the Brief Fatigue Inventory. * Fatigue must have started at or after the diagnosis of ovarian cancer * Completed all primary cancer treatments (surgery, chemotherapy at least 6 months prior), except maintenance therapies * No other planned interventions for fatigue other than current stable medication Exclusion Criteria: * Medically unstable * Acupuncture or acupressure receipt in past year * Have a diagnosis of untreated mood disorder, e.g., bipolar or major depressive disorder * Have a current diagnosis of anemia * Have a current untreated diagnosis of hypothyroidism * Have an initiation, a cessation or change of treatment of any chronic medications, dietary supplements, behavioral therapy, physical therapy, etc., or any planned change of medications, supplements or therapies during the study * Have the possibility of becoming pregnant
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fatigue are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can exercising with your baby reshape postpartum recovery?
- Can MRI and computer models predict how well cancer drugs reach tumors?
- Can a Patient's own immune cells fight ovarian cancer?
- Ovarian Cancer's spread: scientists probe abdominal fluid for clues
- New PET tracer aims to light up hidden cancer targets
- Can inhaled manganese make ovarian cancer immunotherapy hit harder?